Differences in antigenic sites and other functional regions between genotype A and G mumps virus surface proteins

The surface proteins of the mumps virus, the fusion protein (F) and haemagglutinin-neuraminidase (HN), are key factors in mumps pathogenesis and are important targets for the immune response during mumps virus infection. We compared the predicted amino acid sequences of the F and HN genes from Dutch mumps virus samples from the pre-vaccine era (1957–1982) with mumps virus genotype G strains (from 2004 onwards). Genotype G is the most frequently detected mumps genotype in recent outbreaks in vaccinated communities, especially in Western Europe, the USA and Japan. Amino acid differences between the Jeryl Lynn vaccine strains (genotype A) and genotype G strains were predominantly located in known B-cell epitopes and in N-linked glycosylation sites on the HN protein. There were eight variable amino acid positions specific to genotype A or genotype G sequences in five known B-cell epitopes of the HN protein. These differences may account for the reported antigenic differences between Jeryl Lynn and genotype G strains. We also found amino acid differences in and near sites on the HN protein that have been reported to play a role in mumps virus pathogenesis. These differences may contribute to the occurrence of genotype G outbreaks in vaccinated communities.

[1]  S. Rubin,et al.  Recent Mumps Outbreaks in Vaccinated Populations: No Evidence of Immune Escape , 2011, Journal of Virology.

[2]  Shuigeng Zhou,et al.  Prediction of protein-protein interaction sites using an ensemble method , 2009, BMC Bioinformatics.

[3]  M. Dilcher,et al.  Monitoring Viral Genetic Variation as a Tool To Improve Molecular Diagnostics for Mumps Virus , 2018, Journal of Clinical Microbiology.

[4]  W. Donovan,et al.  An outbreak of mumps with genetic strain variation in a highly vaccinated student population in Scotland , 2017, Epidemiology and Infection.

[5]  M. Šantak,et al.  Identification of conformational neutralization sites on the fusion protein of mumps virus. , 2015, The Journal of general virology.

[6]  M. May,et al.  Emergent lineages of mumps virus suggest the need for a polyvalent vaccine. , 2018, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[7]  R. Bremel,et al.  Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes? , 2013, Human vaccines & immunotherapeutics.

[8]  Jing Ren,et al.  Tertiary structure-based prediction of conformational B-cell epitopes through B factors , 2014, Bioinform..

[9]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[10]  R. Lamb,et al.  Fusion Activation through Attachment Protein Stalk Domains Indicates a Conserved Core Mechanism of Paramyxovirus Entry into Cells , 2014, Journal of Virology.

[11]  Robert C. Edgar,et al.  MUSCLE: a multiple sequence alignment method with reduced time and space complexity , 2004, BMC Bioinformatics.

[12]  M. Roelants,et al.  Outbreak of mumps in a vaccinated child population: a question of vaccine failure? , 2004, Vaccine.

[13]  M. James,et al.  Calcium-binding sites in proteins: a structural perspective. , 1991, Advances in protein chemistry.

[14]  E. Norrby,et al.  Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus. , 1990, Virus research.

[15]  P. Minor,et al.  Mumps vaccines and meningitis , 1992, The Lancet.

[16]  S. Vaidya,et al.  Complete genome sequence of mumps viruses isolated from patients with parotitis, pancreatitis and encephalitis in India. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[17]  K. Yamanishi,et al.  Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps virus Urabe vaccine strain. , 1997, Journal of Infectious Diseases.

[18]  H. D. de Melker,et al.  Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection. , 2016, Vaccine.

[19]  Teresa Blasco Máñez a structural perspective, , 2011 .

[20]  K. Wright,et al.  Genetic studies on a mumps vaccine strain associated with meningitis , 1998, Reviews in medical virology.

[21]  S. Plotkin Mumps: A Pain in the Neck. , 2018, Journal of the Pediatric Infectious Diseases Society.

[22]  N. Yoshida,et al.  Leucine at Position 383 of Fusion Protein Is Responsible for Fusogenicity of Wild-Type Mumps Virus in B95a Cells , 2010, Intervirology.

[23]  B. He,et al.  Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China. , 2017, Vaccine.

[24]  R. Myers,et al.  Genomic diversity of mumps virus and global distribution of the 12 genotypes , 2015, Reviews in medical virology.

[25]  M. Koopmans,et al.  Two major mumps genotype G variants dominated recent mumps outbreaks in the Netherlands (2009-2012). , 2014, The Journal of general virology.

[26]  C. Russell,et al.  The structural basis of paramyxovirus invasion , 2006, Trends in Microbiology.

[27]  洋一 中西,et al.  2012: , 2012, Disasters and Social Reproduction.

[28]  M. Šantak,et al.  Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies , 2012, Epidemiology and Infection.

[29]  W. Bellini,et al.  Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. , 2008, The Journal of infectious diseases.

[30]  D. Lackman,et al.  Observations on a mumps epidemic in a virgin population. , 1960, American journal of hygiene.

[31]  K. Dimock,et al.  The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease. , 1996, The Journal of infectious diseases.

[32]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[33]  R. Lamb,et al.  Structure of the Newcastle disease virus F protein in the post-fusion conformation. , 2010, Virology.

[34]  C. Orvell,et al.  Characterization of genotype-specific epitopes of the HN protein of mumps virus. , 1997, The Journal of general virology.

[35]  Deepti D Deobagkar,et al.  Mapping antigenic diversity and strain specificity of mumps virus: a bioinformatics approach. , 2007, Virology.

[36]  Gert Vriend,et al.  Increasing the precision of comparative models with YASARA NOVA—a self‐parameterizing force field , 2002, Proteins.

[37]  N. Abramson,et al.  Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases , 2015, Human vaccines & immunotherapeutics.

[38]  Ilkka Julkunen,et al.  Minor Changes in the Hemagglutinin of Influenza A(H1N1)2009 Virus Alter Its Antigenic Properties , 2011, PloS one.

[39]  Umesh Parashar,et al.  Recent resurgence of mumps in the United States. , 2008, The New England journal of medicine.

[40]  R. Lamb,et al.  Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 fusion protein , 2012, Proceedings of the National Academy of Sciences.

[41]  V. Hutse,et al.  Mumps increase in Flanders, Belgium, 2012-2013: results from temporary mandatory notification and a cohort study among university students. , 2014, Vaccine.

[42]  S. Rubin,et al.  Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  W. Bellini,et al.  Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity. , 2011, The Journal of infectious diseases.

[44]  L. Martens,et al.  Scop3D: Three‐dimensional visualization of sequence conservation , 2015, Proteomics.

[45]  C. Chothia The nature of the accessible and buried surfaces in proteins. , 1976, Journal of molecular biology.

[46]  J. Sohn,et al.  Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements. , 2007, Vaccine.

[47]  Robert C. Edgar,et al.  MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.

[48]  D. Lackman,et al.  Observations on a mumps epidemic in a "virgin" population. 1958. , 1959, American journal of epidemiology.

[49]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[50]  S. Rubin,et al.  Functional consequences of attenuating mutations in the haemagglutinin neuraminidase, fusion and polymerase proteins of a wild-type mumps virus strain. , 2007, The Journal of general virology.

[51]  Pinak Chakrabarti,et al.  Quantifying the accessible surface area of protein residues in their local environment. , 2002, Protein engineering.

[52]  François Stricher,et al.  The FoldX web server: an online force field , 2005, Nucleic Acids Res..

[53]  W. P. Duprex,et al.  Molecular differences between two Jeryl Lynn mumps virus vaccine component strains, JL5 and JL2 , 2009, The Journal of general virology.

[54]  A. Heath,et al.  The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates. , 1993, The Journal of general virology.

[55]  I. Longden,et al.  EMBOSS: the European Molecular Biology Open Software Suite. , 2000, Trends in genetics : TIG.

[56]  I. Herrera-Camacho,et al.  Structure-function analysis of two variants of mumps virus hemagglutinin-neuraminidase protein. , 2009, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[57]  M. Koopmans,et al.  Mumps virus F gene and HN gene sequencing as a molecular tool to study mumps virus transmission. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[58]  S. Fischer,et al.  Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein. , 2001, Virus research.

[59]  B. Haughey,et al.  A pain in the neck , 2014, The Laryngoscope.

[60]  H. D. de Melker,et al.  Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012 , 2014, Emerging infectious diseases.

[61]  Luis E. Lowe,et al.  Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults , 2006, Canadian Medical Association Journal.

[62]  P. Yates,et al.  Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps Urabe vaccine strain. , 1998, The Journal of infectious diseases.

[63]  Y. Grad,et al.  Vaccine waning and mumps re-emergence in the United States , 2017, Science Translational Medicine.

[64]  R. Lamb,et al.  Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. , 2005, Structure.

[65]  P E Bourne,et al.  The Protein Data Bank. , 2002, Nucleic acids research.

[66]  A. Yamada,et al.  Effect on fusion induction of point mutations introduced into the F protein of mumps virus. , 1994, Virology.

[67]  N. Bayley,et al.  Failure , 1890, The Hospital.

[68]  M. Paunio,et al.  Waning antibody levels and avidity: implications for MMR vaccine-induced protection. , 2012, The Journal of infectious diseases.

[69]  E. Norrby,et al.  The mumps virus fusion protein mRNA sequence and homology among the paramyxoviridae proteins. , 1989, The Journal of general virology.

[70]  Gert Vriend,et al.  A series of PDB related databases for everyday needs , 2010, Nucleic Acids Res..

[71]  D. Kohda,et al.  Trisaccharide containing α2,3-linked sialic acid is a receptor for mumps virus , 2016, Proceedings of the National Academy of Sciences of the United States of America.